Shuji Mori
8PUBLICATIONS
1CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (8)
Sort by Publication Date:
|Apr 09, 2025
Metolazone and Azosemide, Clinically Utilized Diuretics, Exhibit Inhibitory Activity for Glyoxalase I.Masahiro Watanabe, Takao Toyomura, Hidenori Wake
|Nov 27, 2023
Cationic ribosomal proteins can inhibit pro-inflammatory action stimulated by LPS+HMGB1 and are hindered by advanced glycation end products.Masahiro Watanabe, Takao Toyomura, Hidenori Wake
|May 25, 2023
Glycolaldehyde-derived advanced glycation end products promote macrophage proliferation via the JAK-STAT signaling pathway.Takao Toyomura, Masahiro Watanabe, Hidenori Wake
|Sep 20, 2022
Nordihydroguaiaretic acid inhibits glyoxalase I, and causes the accumulation of methylglyoxal followed by cell-growth inhibition.Masahiro Watanabe, Takao Toyomura, Ryo Ikegami
|Jan 21, 2022
Identification of ribosomal protein L9 as a novel regulator of proinflammatory damage-associated molecular pattern molecules.Masahiro Watanabe, Takao Toyomura, Hidenori Wake
|Sep 05, 2020
Advanced glycation end products (AGEs) synergistically potentiated the proinflammatory action of lipopolysaccharide (LPS) and high mobility group box-1 (HMGB1) through their direct interactions.Masahiro Watanabe, Takao Toyomura, Mayuko Tomiyama
Pageof 2
